Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

Ann: G Medical Approved to Trade on US OTCQB Market, page-51

First 51 Last

Share
Profile

Follow
Galilee13

957 Posts.

1843

18/02/20

15:02

Post #: 42998995
Share

Originally posted by Ruby15: ↑

Hi Galilee13,

The factory in China needs NMPA before they can be sold to the Chinese consumer. It is IMO only that this is where GMV will need to do a massive advertising program to launch the Prizma Jacket once approval has been granted.

For 61212305, yes the Prizma Jacket can be made in Israel and sold globally, however it is not cost effective. Once the first big order from Taiwan is exucuted, this should be the signal for the Chinese Factory to start ramping up the manufacture of components. I still say that given China's 1.2 Billion population, this is where GMV will make the profits.

The one question that I would like Dr G to answer, is the where are we at with the FDA?

Cheers Rubes

Expand

Hi Rubes

Yes I understand that. Just saying there are more possibilities in the short term to get the factory started.

And Yacov will provide an update on the FDA for the patch and prizma in the early feb update. I am told...

G13

GMV Price at posting: 8.9¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 10 more messages in this thread...

First 51 Last

Add GMV (ASX) to my watchlist